Category: Uncategorized
BD Breaks Ground at I.D.E.A. Tempe Campus
Global Medical Technology Company To Be Anchor Tenant at New Campus TEMPE, Ariz., Oct. 3, 2018 /PRNewswire/ — Officials from BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, were joined today by Gov. Doug Ducey, Tempe Mayor Mark Mitchell and representatives of The Boyer Company to officially break ground on the new I.D.E.A. (Innovation, Discovery, Education and Arts)... Read more
【Delayed】Notice Regarding Business Reorganization by Simplified Absorption-type Company Split
This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more
Anton Paar ShapeTec upgrades machinery
2018-09-19 | Corporate Anton Paar ShapeTec in Wunschuh near Graz (Austria) is currently in high demand for contract manufacturing of high-precision metal parts. So it was apparent to expand the machinery and production capacities. Recently, a 5-axis milling machine and a turn-mill center went into service. Another new turn-mill center has been in operation since early... Read more
Pacific Biosciences of California, Inc. Announces Pricing of Public Offering of Common Stock
MENLO PARK, Calif., Sept. 12, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”) today announced that it has priced its previously announced underwritten public offering of 14,117,647 shares of its common stock at a price to the public of $4.25 per share. The offering is expected to close on or... Read more
Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock
MENLO PARK, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Pacific Biosciences also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the... Read more
Changes to the Roche Corporate Executive Committee
Basel, 28 August 2018 Changes to the Roche Corporate Executive Committee Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Roland Diggelmann, CEO Diagnostics Division and member of the Corporate Executive Committee, will be leaving Roche to pursue his career outside of the company effective 30 September 2018. Until a successor is named, Michael Heuer,... Read more